Cargando…
1591P Immune response after vaccination against SARS-COV-2 in lung cancer (LC) patients (p). Prospective study in the Medical Oncology Department at the Catalan Institute of Oncology-Badalona, Spain: COVID-lung vaccine
Autores principales: | Felip, E., Hernandez, A., Notario, L., Cucurull, M., Quirant, B., Saigí, M., Gómez-Castellà, R., Estevez-Macas, E., Fonollosa, S. Coll, Bertral, P. Torres, Costa, E. Carcereny, Domenech, M., Estival, A., Paradís, A. López, Badía, A. Pous, Marín, M. Romeo, Bueno, M.T. Moran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454346/ http://dx.doi.org/10.1016/j.annonc.2021.08.1584 |
Ejemplares similares
-
OA06.04 Immune Response after SARS-CoV-2 Vaccination in Lung Cancer Patients. Update of the Covid Lung Vaccine Cohort
por: Hernandez, A., et al.
Publicado: (2022) -
Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
por: Cucurull, Marc, et al.
Publicado: (2022) -
Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study
por: Hernandez, Ainhoa, et al.
Publicado: (2022) -
Detection and Prevalence of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium in Badalona, Spain
por: Rivaya, Belén, et al.
Publicado: (2022) -
HDR and LDR Brachytherapy in the Treatment of Lip Cancer: the Experience of the Catalan Institute of Oncology
por: Ayerra, Arrate Querejeta, et al.
Publicado: (2010)